Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3980304rdf:typepubmed:Citationlld:pubmed
pubmed-article:3980304lifeskim:mentionsumls-concept:C0017436lld:lifeskim
pubmed-article:3980304lifeskim:mentionsumls-concept:C1317574lld:lifeskim
pubmed-article:3980304lifeskim:mentionsumls-concept:C1441457lld:lifeskim
pubmed-article:3980304lifeskim:mentionsumls-concept:C1697858lld:lifeskim
pubmed-article:3980304lifeskim:mentionsumls-concept:C2349101lld:lifeskim
pubmed-article:3980304pubmed:issue2lld:pubmed
pubmed-article:3980304pubmed:dateCreated1985-5-14lld:pubmed
pubmed-article:3980304pubmed:abstractTextThe MS-2 automated system was compared with Rosco Neosensitabs agar diffusion for the gentamicin susceptibility of a group of 267 organisms isolated from clinical material. With Rosco Neosensitabs agar diffusion agreement with reference minimal inhibitory concentrations was 98.5%, while with the MS-2 system it was 100% if calcium and magnesium-supplemented MS-2 broth was used.lld:pubmed
pubmed-article:3980304pubmed:languageenglld:pubmed
pubmed-article:3980304pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3980304pubmed:citationSubsetIMlld:pubmed
pubmed-article:3980304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3980304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3980304pubmed:statusMEDLINElld:pubmed
pubmed-article:3980304pubmed:monthFeblld:pubmed
pubmed-article:3980304pubmed:issn0021-8847lld:pubmed
pubmed-article:3980304pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:3980304pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:3980304pubmed:issnTypePrintlld:pubmed
pubmed-article:3980304pubmed:volume58lld:pubmed
pubmed-article:3980304pubmed:ownerNLMlld:pubmed
pubmed-article:3980304pubmed:authorsCompleteYlld:pubmed
pubmed-article:3980304pubmed:pagination235-8lld:pubmed
pubmed-article:3980304pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:3980304pubmed:meshHeadingpubmed-meshheading:3980304-...lld:pubmed
pubmed-article:3980304pubmed:meshHeadingpubmed-meshheading:3980304-...lld:pubmed
pubmed-article:3980304pubmed:meshHeadingpubmed-meshheading:3980304-...lld:pubmed
pubmed-article:3980304pubmed:meshHeadingpubmed-meshheading:3980304-...lld:pubmed
pubmed-article:3980304pubmed:year1985lld:pubmed
pubmed-article:3980304pubmed:articleTitleA note on gentamicin susceptibility testing: the validity of the MS-2 system and Rosco Neosensitabs agar diffusion.lld:pubmed
pubmed-article:3980304pubmed:publicationTypeJournal Articlelld:pubmed